TY - JOUR
T1 - Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery
AU - Tarantini, Giuseppe
AU - Tang, Gilbert
AU - Nai Fovino, Luca
AU - Blackman, Daniel
AU - Van Mieghem, Nicolas M.
AU - Kim, Won Keun
AU - Karam, Nicole
AU - Carrilho-Ferreira, Pedro
AU - Fournier, Stephane
AU - Pręgowski, Jerzy
AU - Fraccaro, Chiara
AU - Vincent, Flavien
AU - Campante Teles, Rui
AU - Mylotte, Darren
AU - Wong, Ivan
AU - Bieliauskas, Gintautas
AU - Czerny, Martin
AU - Bonaros, Nikolaos
AU - Parolari, Alessandro
AU - Dudek, Darius
AU - Tchetche, Didier
AU - Eltchaninoff, Hélène
AU - de Backer, Ole
AU - Stefanini, Giulio
AU - Sondergaard, Lars
N1 - Publisher Copyright:
© Europa Digital & Publishing 2023.
PY - 2023/5/15
Y1 - 2023/5/15
N2 - Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of particular importance with the extension of the procedure to younger and lower-risk patients. Yet, the preprocedural diagnostic evaluation and the indications for treatment of significant CAD in TAVI candidates remain a matter of debate. In this clinical consensus statement, a group of experts from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Society of Cardiology (ESC) Working Group on Cardiovascular Surgery aims to review the available evidence on the topic and proposes a rationale for the diagnostic evaluation and indications for percutaneous revascularisation of CAD in patients with severe aortic stenosis undergoing transcatheter treatment. Moreover, it also focuses on commissural alignment of transcatheter heart valves and coronary re-access after TAVI and redo-TAVI.
AB - Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of particular importance with the extension of the procedure to younger and lower-risk patients. Yet, the preprocedural diagnostic evaluation and the indications for treatment of significant CAD in TAVI candidates remain a matter of debate. In this clinical consensus statement, a group of experts from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Society of Cardiology (ESC) Working Group on Cardiovascular Surgery aims to review the available evidence on the topic and proposes a rationale for the diagnostic evaluation and indications for percutaneous revascularisation of CAD in patients with severe aortic stenosis undergoing transcatheter treatment. Moreover, it also focuses on commissural alignment of transcatheter heart valves and coronary re-access after TAVI and redo-TAVI.
UR - http://www.scopus.com/inward/record.url?scp=85159154982&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-22-00958
DO - 10.4244/EIJ-D-22-00958
M3 - Article
C2 - 36811935
AN - SCOPUS:85159154982
SN - 1774-024X
VL - 19
SP - 37
EP - 52
JO - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
JF - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
IS - 1
ER -